Literature DB >> 10612889

The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis.

I Reiter-Owona1, E Petersen, D Joynson, H Aspöck, M L Dardé, R Disko, O Dreazen, H Dumon, R Grillo, U Gross, M Hayde, R Holliman, D O Ho-Yen, K Janitschke, P A Jenum, K Naser, M Olszewski, P Thulliez, H M Seitz.   

Abstract

The dye test for the detection of Toxoplasma-specific antibodies was first described by Sabin and Feldman 50 years ago. The test is highly specific and sensitive and considerable information is available on the development and persistence of dye test antibodies after primary Toxoplasma infection. However, the test uses live Toxoplasma gondii and is now only employed in a few laboratories. It is still the reference method for the serodiagnosis of toxoplasmosis, and a multicentre study comparing dye test results between different laboratories was much needed. We report in this article the results of a multicentre evaluation of the test involving nineteen laboratories in eight countries. The study revealed overall satisfactory standardization between the laboratories, but there were differences in the test protocols, the use of reference/standard preparations and the interpretation of results. There is still no agreement on the level of dye test values which reflect infection with the parasite, and conversion from titres to international units (IUs) did not improve standardization. However, the results indicated that a value of > 4 IU or a titre of 1:16 met the definition of positivity of most participants. We recommend that the dye test be retained as a reference method and that interlaboratory standardization be improved by the use of a common protocol and the expression of results in titres.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10612889      PMCID: PMC2557752     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  23 in total

1.  Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey.

Authors:  Li Liang; Mert Döşkaya; Silvia Juarez; Ayşe Caner; Algis Jasinskas; Xiaolin Tan; Bettina E Hajagos; Peter J Bradley; Metin Korkmaz; Yüksel Gürüz; Philip L Felgner; D Huw Davies
Journal:  Mol Cell Proteomics       Date:  2011-04-21       Impact factor: 5.911

2.  Serologic evidence that ascaris and toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians.

Authors:  Courtney Ek; Mark T Whary; Melanie Ihrig; Luis E Bravo; Pelayo Correa; James G Fox
Journal:  Helicobacter       Date:  2012-04       Impact factor: 5.753

3.  European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.

Authors:  Eskild Petersen; Maria Victoria Borobio; Edward Guy; Oliver Liesenfeld; Valeria Meroni; Anne Naessens; Emma Spranzi; Philippe Thulliez
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot.

Authors:  Arnaud Maudry; Gautier Chene; Rémi Chatelain; Hugues Patural; Bahrie Bellete; Bernard Tisseur; Jamal Hafid; Hélène Raberin; Sophie Beretta; Roger Tran Manh Sung; Georges Belot; Pierre Flori
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

5.  Utility of immunoblotting for early diagnosis of toxoplasmosis seroconversion in pregnant women.

Authors:  C Jost; F Touafek; A Fekkar; R Courtin; M Ribeiro; D Mazier; L Paris
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

6.  Discrepancies between a new highly sensitive Toxoplasma gondii ELISA assay and other reagents: interest of Toxo IgG Western blot.

Authors:  F Leslé; F Touafek; A Fekkar; D Mazier; L Paris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

7.  Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis.

Authors:  O Villard; B Cimon; C L'Ollivier; H Fricker-Hidalgo; N Godineau; S Houze; L Paris; H Pelloux; I Villena; E Candolfi
Journal:  J Clin Microbiol       Date:  2016-10-12       Impact factor: 5.948

8.  Simple and efficient method for measuring anti-toxoplasma immunoglobulin antibodies in human sera using complement-mediated lysis of transgenic tachyzoites expressing beta-galactosidase.

Authors:  C Dando; K E Gabriel; J S Remington; S F Parmley
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

9.  Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection.

Authors:  Oluwatoyin Falusi; Audrey L French; Eric C Seaberg; Phyllis C Tien; D Heather Watts; Howard Minkoff; Eva Piessens; Andrea Kovacs; Kathryn Anastos; Mardge H Cohen
Journal:  Clin Infect Dis       Date:  2002-11-11       Impact factor: 9.079

10.  Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women.

Authors:  David C Kasper; Andrea R Prusa; Michael Hayde; Nicole Gerstl; Arnold Pollak; Kurt R Herkner; Rosmarie Reiter-Reisacher
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.